Biotech Analysts Devarakonda and Jahangiri, along with a hematologist and oncologist expert, focus on MDS (relevant companies BMY, KROS, ABBV, CRIS) on an Analyst/Industry conference call to be held on February 26 at 12 pm. Webcast Link
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on BMY:
- C4 Therapeutics price target raised to $13 from $12 at Stifel
- Bristol Myers announces expiration of tender offer for RayzeBio
- Bristol Myers announces positive CHMP opinion for Reblozyl
- Bristol-Myers Squibb’s $11 Billion Notes Issuance for Acquisitions
- Immunocore enters trial collaboration, supply agreement with Bristol Myers